Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Daylight Mediated Photodynamic Therapy for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)

NCT02464709 is registered in ClinicalTrials.gov with Joint Authority for Päijät-Häme Social and Health Care as lead sponsor.

NCT NCT02464709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02464709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Daylight Mediated Photodynamic Therapy for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)
Lead sponsor
Joint Authority for Päijät-Häme Social and Health Care
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2015
Completion date
October 31, 2017
Enrollment
72 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis, natural daylight photodynamic therapy